bluebird bio Inc (NAS:BLUE)
$ 0.6078 0.0338 (5.89%) Market Cap: 117.15 Mil Enterprise Value: 240.30 Mil PE Ratio: 0 PB Ratio: 0.29 GF Score: 25/100

Q3 2020 bluebird bio Inc Earnings Call Transcript

Nov 04, 2020 / 09:30PM GMT
Release Date Price: $37.9 (+7.33%)
Operator

Good afternoon, ladies and gentlemen, and welcome to the bluebird bio, Inc. Third Quarter 2020 Earnings Conference Call. (Operator Instructions) As a reminder, this conference call is being recorded. I would now like to turn the conference over to your host speaker, Ingrid Goldberg. Please go ahead.

Ingrid Goldberg
bluebird bio, Inc. - VP of IR

Thank you. And good evening, everyone. This is Ingrid Goldberg, Investor Relations at bluebird bio. And I'm joined today by several members of the bluebird management team to discuss our third quarter earnings and business update.

Before we begin, I would like to remind everyone that our discussion today includes forward-looking statements under the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are based on current expectations and assumptions that are subject to risks and uncertainties, and actual results may differ materially from those expressed today due to a variety of factors. Additional information concerning these risk factors is contained in our filings with the SEC

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot